We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Protein Supports Optimal Vascular System Performance

By LabMedica International staff writers
Posted on 01 May 2018
A protein has been identified that acts as a sensor of mechanical stimulation and is essential for sensing blood flow and supporting optimal performance of the vascular system.

The process of mechanotransduction plays a crucial role in vascular biology. More...
One example of this is the local regulation of vascular resistance via flow-mediated dilation (FMD). Impairment of this process is a hallmark of endothelial dysfunction and a precursor to a wide array of vascular diseases, such as hypertension and atherosclerosis. However, the molecules responsible for sensing flow (shear stress) within endothelial cells remain largely unknown.

To determine which molecules are capable of sensing shear stress, investigators at the Scripps Research Institute (La Jolla, CA, USA) designed a 384-well screening system that applied shear stress to cultured cells. The system used turbulent movement of liquid to mimic fluid flow in blood vessels. The instrument employed 384 pistons to push the fluid up and down over a bed of cells, placed in 384 wells on a microtiter plate. This motion simulated how blood would put pressure on those cells.

The investigators tested a series of cell lines, some of which overexpressed proteins potentially linked to pressure sensing. The expression of different candidate genes in each of the 384 wells was "knocked down" with siRNA (short interfering RNA), and the modified cells were evaluated to determine if that specific gene was required for responding to shear stress.

Results published in the April 19, 2018, online edition of the journal Cell revealed that the protein GPR68 was necessary and sufficient for shear stress responses. This protein is a proton-sensing G protein-coupled receptor, a transmembrane receptor that senses acidic pH. This class of G protein-coupled receptors is activated when extracellular pH falls into the range of 6.4-6.8 (typical values are above 7.0). The functional role of the low pH sensitivity of the proton-sensing G protein-coupled receptors is being studied in several tissues where cells respond to conditions of low pH including bone and inflamed tissues.

Data obtained during the current study showed that GPR68 was expressed in endothelial cells of small-diameter arteries. Importantly, Gpr68-deficient mice displayed markedly impaired acute FMD and chronic flow-mediated outward remodeling in mesenteric arterioles.

“In a model organism, this protein is essential for sensing blood flow, and the proper functioning of the vascular system,” said senior author Dr. Ardem Patapoutian, a professor at the Scripps Research Institute. "It has been known for decades that blood vessels sense changes in blood flow rate, and this information is crucial in regulating blood vessel dilation and controlling vascular tone. Despite the importance of this process, the molecules involved within arteries to sense blood flow have remained unknown. Future work will explore the role of GPR68 in clinically relevant cardiovascular diseases. We are also exploring the possibility of using small molecules to modulate the function of GPR68, as such molecules could be beneficial in the clinic.”

Related Links:
Scripps Research Institute


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Glucose Tolerance Test
NERL Trutol
New
Enterovirus Test
Quanty Enterovirus System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.